MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Amryt inks distribution deal with Swixx for cholesterol disorder drug

StockMarketWire.com

Biopharmaceutical company Amryt inked an agreement with Switzerland-based Swixx BioPharma to distribute the company's for cholesterol disorder drug across the Central and Eastern Europe.

Under the agreement, Swixx would distribute lojuxta from October 2020 in Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Kosovo, Latvia, Lithuania, Montenegro, North Macedonia, Poland, Romania, Serbia and Slovakia.

From January 2021, Swixx's distribution of lojuxta would expand into Czech Republic, Hungary and Slovenia.



At 8:44am: (LON:AMYT) Amryt Pharma share price was +2p at 197p


Story provided by StockMarketWire.com